Literature DB >> 1598903

Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease.

P Margaritte1, C Bonaiti-Pellie, M C King, F Clerget-Darpoux.   

Abstract

Lod scores for linkage between familial breast and ovarian cancer and markers on chromosome 17q21 are more frequently positive among families with disease diagnosed at younger ages than they are among older-onset families, suggesting that linkage is restricted to early-onset disease. However, for late-onset cases, the relative probability of sporadic rather than inherited disease is higher than previously suggested. If this correction is made, then later-onset families are much less informative; linkage heterogeneity based on age at onset is no longer significant; and for the sample of families as a whole, linkage is significant at a recombination fraction since demonstrated to be close to the correct local. There is probably more than one gene for inherited breast cancer, but heterogeneity may not be due to age at disease onset.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598903      PMCID: PMC1682567     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  TESTING FOR HETEROGENEITY OF RECOMBINATION FRACTION VALUES IN HUMAN GENETICS.

Authors:  C A SMITH
Journal:  Ann Hum Genet       Date:  1963-11       Impact factor: 1.670

2.  The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

3.  Closing in on a breast cancer gene on chromosome 17q.

Authors:  J M Hall; L Friedman; C Guenther; M K Lee; J L Weber; D M Black; M C King
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  Segregation and linkage analysis of nine Utah breast cancer pedigrees.

Authors:  D T Bishop; L Cannon-Albright; T McLellan; E J Gardner; M H Skolnick
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

5.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

6.  Inheritance of proliferative breast disease in breast cancer kindreds.

Authors:  M H Skolnick; L A Cannon-Albright; D E Goldgar; J H Ward; C J Marshall; G B Schumann; H Hogle; W P McWhorter; E C Wright; T D Tran
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

7.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Genetic epidemiology of breast cancer in Britain.

Authors:  L Iselius; J Slack; M Littler; N E Morton
Journal:  Ann Hum Genet       Date:  1991-05       Impact factor: 1.670

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  19 in total

1.  Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.

Authors:  Weiva Sieh; Yoonha Choi; Nicola H Chapman; Ulla-Katrina Craig; Ellen J Steinbart; Joseph H Rothstein; Kiyomitsu Oyanagi; Ralph M Garruto; Thomas D Bird; Douglas R Galasko; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Hum Mol Genet       Date:  2009-06-30       Impact factor: 6.150

Review 2.  Molecular genetics of familial breast-ovarian cancer.

Authors:  E J van Rensburg; B A Ponder
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

3.  Is there heterogeneity of age at onset for breast cancer?

Authors:  J Ott; C Mérette
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

4.  Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease.

Authors:  Alexander H Li; Alanna C Morrison; Christie Kovar; L Adrienne Cupples; Jennifer A Brody; Linda M Polfus; Bing Yu; Ginger Metcalf; Donna Muzny; Narayanan Veeraraghavan; Xiaoming Liu; Thomas Lumley; Thomas H Mosley; Richard A Gibbs; Eric Boerwinkle
Journal:  Nat Genet       Date:  2015-04-27       Impact factor: 38.330

Review 5.  Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.

Authors:  A M Bowcock
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

6.  Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.

Authors:  S Mazoyer; P Lalle; S A Narod; Y J Bignon; F Courjal; B Jamot; B Dutrillaux; D Stoppa-Lyonnett; H Sobol
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  A breast-ovarian cancer susceptibility gene maps to chromosome 17q21.

Authors:  J Feunteun; S A Narod; H T Lynch; P Watson; T Conway; J Lynch; J Parboosingh; P O'Connell; R White; G M Lenoir
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

Review 9.  Familial risk and genetic susceptibility for breast cancer.

Authors:  N Eby; J Chang-Claude; D T Bishop
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

10.  Chromosome 14 and late-onset familial Alzheimer disease (FAD).

Authors:  G D Schellenberg; H Payami; E M Wijsman; H T Orr; K A Goddard; L Anderson; E Nemens; J A White; M E Alonso; M J Ball
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.